1740 results about "Decarboxylation" patented technology

Described herein are compositions and methods for using metal oxides to upgrade oil. Metal oxides may be used as catalysts to reduce the TAN of the oil by converting carboxylic acids such as naphthenic acids into non-corrosive products. In some cases, the conversion occurs by a decarboxylation of the carboxylic acid to produce CO₂. A second process promoted by metal oxides is hydrocarbon cracking. Cracking decreases the viscosity and increases the API, and produces lower molecular-weight hydrocarbons that are useful for many fuels and lubricants. Reductions in TAN and the increases in API improve the quality of increase the value of oil.

A triglyceride-to-fuel conversion process including the steps of (a) preconditioning unsaturated triglycerides by catalytic conjugation, cyclization, and cross-link steps; (b) contacting the modified triglycerides with hot-compressed water containing a catalyst, wherein cracking, hydrolysis, decarboxylation, dehydration, aromatization, or isomerization, or any combination thereof, of the modified triglycerides produce a crude hydrocarbon oil and an aqueous phase containing glycerol and lower molecular weight molecules, and (c) refining the crude hydrocarbon oil to produce various grades of biofuels. A triglyceride-to-fuel conversion process further including the steps of (a) carrying out anaerobic fermentation and decarboxylation/dehydration, wherein the anaerobic fermentation produces hydrogen, volatile acids, and alcohols from fermentable feedstocks, and the decarboxylation/dehydration produces alkenes from the volatile acids and alcohols, respectively; (b) feeding the alkenes to the cyclization process; (c) feeding the hydrogen to the post refining process; and (d) recycling the aqueous phase containing glycerol to the decarboxylation/dehydration process. A biofuel composition including straight-chain, branched and cyclo paraffins, and aromatics. The paraffins are derived from conversion of triglycerides. The aromatics are derived from conversion of either triglycerides, petroleum, or coal.

A method that produces coupled radical products from biomass. The method involves obtaining a lipid or carboxylic acid material from the biomass. This material may be a carboxylic acid, an ester of a carboxylic acid, a triglyceride of a carboxylic acid, or a metal salt of a carboxylic acid, or any other fatty acid derivative. This lipid material or carboxylic acid material is converted into an alkali metal salt. The alkali metal salt is then used in an anolyte as part of an electrolytic cell. The electrolytic cell may include an alkali ion conducting membrane (such as a NaSICON membrane). When the cell is operated, the alkali metal salt of the carboxylic acid decarboxylates and forms radicals. Such radicals are then bonded to other radicals, thereby producing a coupled radical product such as a hydrocarbon. The produced hydrocarbon may be, for example, saturated, unsaturated, branched, or unbranched, depending upon the starting material.

There is disclosed a method for conversion of crude tall oil into high-quality diesel fuels comprising the steps of: (a) removal of non-oil contaminants present in the crude tall oil and recovering valuable organic compounds present in the crude tall oil, thereby forming a refined tall oil stream; (b) removal of the volatile fraction of the refined tall oil stream from step a), thereby forming a volatiles free oil stream comprising organic components with boiling points, at atmospheric pressure, of 170 degrees C. or higher; (c) separation in a vacuum distillation column of the volatiles free oil stream of step b) into two process streams or phases wherein a first process stream or phase is substantially comprising components with boiling points, at atmospheric pressure, in the range of 170-400 degrees C. and a second process stream or phase is substantially comprising components with boiling points, at atmospheric pressure, over 400 degrees C.; (d) lowering the oxygen content in the stream comprised of components with boiling points in the range 200-400 degrees C. from step c) by decarboxylation and/or decarbonylation.

The invention discloses a synthetic method for loxoprofen sodium, which is prepared by taking methyl acetophenone as an initial raw material through reduction, acylation or halogen substituent, cyanation, hydrolysis, bromination, condensation, decarboxylation and salifying. The method has the advantages of easily obtained raw material, unique technology, simple and stable operation, and high productive rate in each step of reaction; and all solvents used in the synthesis process can be recycled, so the production cost is reduced greatly. Tests show that the obtained product has reliable quality and stable performance, and can be further used for making preparation of non-steroidal anti-inflammatory drugs such as the loxoprofen sodium.

The present invention provides a processes, having practical utility, for preparing 2-oxindoles, N-hydroxy-2-oxindoles, or mixtures thereof comprising: catalytically hydrogenating a 2-nitroarylmalonate diester to produce a 2-(N-hydroxyamino)arylmalonate diester, a 2-aminoarylmalonate diester, or mixtures thereof as a first reaction intermediate; cyclizing, by intramolecular aminolysis of one ester group, the first reaction intermediate to produce a N-hydroxy-2-oxindole-3-carboxylate ester, 2-oxindole-3-carboxylate ester, or mixtures thereof as a second reaction intermediate; and hydrolyzing and decarboxylating the remaining ester group of the second reaction intermediate to produce the N-hydroxy-2-oxindole, the 2-oxindole, or mixtures thereof, wherein the cyclization reaction and the hydrolysis and decarboxylation reaction are conducted in situ with the catalytic hydrogenation reaction without isolation of said reaction intermediates.

The invention describes a process for preparing acetone starting from acetyl-coenzyme A comprising process steps A. enzymatic conversion of acetyl-CoA into acetoacetyl-CoA B. enzymatic conversion of acetoacetyl-CoA into acetoacetate and CoA and C. decarboxylation of acetoacetate to acetone and CO₂, which is characterized in that the coenzyme A is not transferred in process step B to an acceptor molecule. In addition, process step B is surprisingly catalysed by enzymes of the classes of acyl-CoA thioesterase, acyl-CoA synthetase or acyl-CoA thiokinase.

A completely novel metabolic pathway is concerned, because the enzymatic hydrolysis of acetoacetyl-CoA without simultaneous transfer of CoA to a receptor molecule has never previously been described for any microbial enzyme.

The invention concerns a process for hydrodeoxygenation of feeds derived from renewable sources with conversion by decarboxylation/decarbonylation limited to at most 10%, using a bulk or supported catalyst comprising an active phase constituted by at least one element from group VIB and at least one element from group VIII, said elements being in the sulphide form, and the atomic ratio of the metal (or metals) from group VIII to the metal (or metals) from group VIB being strictly more than 0 and less than 0.095, said process being carried out at a temperature in the range 120° C. to 450° C., at a pressure in the range 1 MPa to 10 MPa, at an hourly space velocity in the range 0.1 h⁻¹ to 10 h⁻¹, and in the presence of a total quantity of hydrogen mixed with the feed such that the hydrogen/feed ratio is in the range 50 to 3000 Nm³ of hydrogen/m³ of feed.

The invention discloses a synthesis method of a pharmaceutical intermediate of tertiary butyl-(2-(biphenyl-4-yl)-1-(methylol) ethyl) carbamate, which comprises the steps that: diethyl acetamidornalonate and 4-substituent biphenyl are taken as initial raw materials and undergone six steps of reactions including condensation, decarboxylation, hydrolysis, reduction and acylation to obtain the tertiary butyl-(2-(biphenyl-4-yl)-1-(methylol) ethyl) carbamate. The method of the invention has the advantages of available raw materials, convenient operation, high reaction yield rate, recoverable solvents used in the synthesis course, thereby reducing environmental pollution and greatly reducing production cost; according to test results, the products obtained by the method has reliable quality and stable performance.

The present application provides a process to produce fluorinated vinyl ether by reacting a 2-alkoxypropionyl fluoride with a metal carbonate under anhydrous conditions in a stirred bed reactor at a temperature above the decarboxylation temperature of an intermediate carboxylate to produce a fluorinated vinyl ether. The process is carried out in the absence of solvent. With the process described, fluorinated vinyl ether of a high purity can be obtained in a high throughput manner.

The invention discloses a method for using non-noble metal catalyst to catalyze decarboxylation of saturated fatty acid to prepare long-chain alkane. The method includes: 1) adding saturated fatty acid and a non-noble metal catalyst into a high-temperature and high-pressure reaction kettle; 2) conducting heating to 300-390DEG C to carry out decarboxylation for 0.5-8h; 3) cooling the decarboxylation product, conducting dissolving by an organic solvent, and performing filtering to obtain a liquid product and a solid catalyst; and 4) cleaning and regenerating the non-noble metal catalyst for reuse. The non-noble metal catalyst is prepared by a co-precipitation method or impregnation method, and the catalyst is regenerated through reductive calcination in hydrogen. The reaction process involved in the invention has the characteristics of no need for a solvent, low energy consumption, and zero emission. The non-noble metal catalyst can effectively catalyze decarboxylation, the catalyst is low in cost and is easy to recover, and the process is simple and green.

The invention is a process for the controlled decarboxylation of cannabis wherein Medicinal Delta-9 tetrahydrocannabinol (Δ⁹-THC) and other cannabinoid medicinal substances are decarboxylated through a chemical reaction facilitated by a cofactor. The amount of medicinal cannabis decarboxylated will be directly proportional to the amount of cofactor used. Use a small amount of the cofactor and only some of the medicinal cannabis contained in raw cannabis will be converted from an acidic form into a non-acidic form. Use a large amount of the cofactor and most or all of the medicinal cannabis will be decarboxylated. The reaction is proportional to the molar mass of cofactor.

The present invention is directed to methods for processing fatty acids to provide for base oil and transportation fuels, wherein decarboxylation-coupling dimerization of fatty acids provides dimer ketones from which the base oils and transportation fuels may be produced.

The invention provides methods for the production of erythrose and/or erythritol. Preferably, the methods include the step of electrolytic decarboxylation of a ribonic acid or arabinonic acid reactant to produce erythrose. Optionally, the reactant can be obtained from a suitable hexose sugar, such as allose, altrose, glucose, fructose or mannose. The erythrose product can be hydrogenated to produce erythritol.

The present invention concerns a new method for the biological preparation of a diol comprising culturing a microorganism genetically modified for the bioproduction of an aliphatic diol, wherein the microorganism comprises a metabolic pathway for the decarboxylation of a hydroxy-2-keto-aliphatic acid metabolite with an enzyme having a 2-keto acid decarboxylase activity, the product obtained from said decarboxylation step being further reduced into the corresponding aliphatic diol, and wherein the microorganism is genetically modified for the improved production of said hydroxy-2-keto-aliphatic acid metabolite.

The invention also concerns a modified microorganism for the production of an aliphatic diol.

The invention discloses a productive technology of vanlillin by a glyoxylic acid method. The productive technology comprises a synthesis process, a fractionation process and a purification process, wherein the synthesis process comprises condensation treatment, oxidation treatment and decarboxylation treatment of methyl catechol and glyoxylic acid. The productive technology particularly comprisesthe following steps: respectively converting the methyl catechol and the glyoxylic acid into guaiacol sodium and sodium glyoxylate in a sodium hydroxide system; carrying out condensation treatment onthe guaiacol sodium and the sodium glyoxylate; after recovering the unreacted methyl catechol in a condensation liquid, carrying out oxidation treatment, namely carrying out catalytic oxidation on anethanol group in 4-hydroxy-3-methoxybenzene sodium glycolate by using copper oxide in the sodium hydroxide system to form a ketone group, thereby generating a corresponding ketonic acid compound; after separating red copper oxide particles from an oxidation liquid, carrying out decarboxylation treatment, namely using sulfuric acid to acidize the oxidation liquid, and simultaneously converting an acid group in the ketonic acid compound into carbon dioxide so as to generate 4-hydroxy-3- methoxybenzaldehyde; and carrying out the fractionation process and the purification process to obtain the vanlillin.

Ketones, specifically Methyl ethyl ketone (“MEK”) and octanedione, may be formed from six carbon sugars. This process involves obtaining a quantity of a six carbon sugar and then reacting the sugar to form levulinic acid and formic acid. The levulinic acid and formic acid are then converted to an alkali metal levulinate and an alkali metal formate (such as, for example, sodium levulinate and sodium formate.) The alkali metal levulinate is placed in an anolyte along with hydrogen gas that is used in an electrolytic cell. The alkali metal levulinate within the anolyte is decarboxylated to form MEK radicals, wherein the MEK radicals react with hydrogen gas to form MEK, or MEK radicals react with each other to form octanedione. The alkali metal formate may also be decarboxylated in the cell, thereby forming hydrogen radicals that react with the MEK radicals to form MEK.

The invention relates to the technical field of drug synthesis, and particularly relates to a synthetic method of kyprolis. The synthetic method comprises the following steps: carrying out condensation reaction on morpholine-4-base acetic acid, L-homophenylalanine ester and salt, and then carrying out decarboxylation protection to generate a compound V; carrying out the condensation reaction on the decarboxylation, the salt and N-Boc-L-leucine, and then carrying out deamination protection to generate a compound VI; carrying out the condensation reaction on the compound V and the compound VI, and then carrying out decarboxylation protection to generate a compound VII; carrying out the condensation reaction on the compound VII and a compound VIII to obtain the kyprolis. The method disclosed by the invention can be used for enhancing the reaction yield by adopting a converging synthetic method; the used reagent is easy, convenient, easy to obtain and less in pollution. The process disclosed by the invention only relates to the condensation and deprotection between amino acids and is simple and controllable in reaction and suitable for industrial production.